NCI Seeks Cancer Patients

National Cancer Institute researchers are testing a new treatment in people with liver cancer (hepatocellular carcinoma) or biliary tract carcinoma. The treatment uses tremelimumab given in combination with durvalumab and/or trans-arterial catheter chemoembolization. Participants do not pay for tests, treatments or procedures. Travel may be reimbursed. Contact the Clinical Center Office of Patient Recruitment at 800-411-1222 (800-877-8339 TTY/ASCII) or prpl@cc.nih.gov. Refer to study 16-C-0135. Read more at https://go.usa.gov/xpEKb.

Patients with Anemia Sought

NHLBI is conducting an investigational treatment study with eltrombopag to help patients with Diamond-Blackfan anemia (DBA). For more information, call the Clinical Center Office of Patient Recruitment, 866-444-2214 or email prpl@cc.nih.gov, or if you need accommodation, the Federal Relay Service (https://www.federalrelay.us/federal-relay-services). Refer to study 20-H-0021. Read more at https://go.usa.gov/xdNyc.

Patients with OI Needed for Study

NICHD researchers seek individuals with osteogenesis imperfecta (OI) for study participation. Now enrolling children up to age 12 and people with OI of any age who were previously seen at NIH. For more information, call the Clinical Center Office of Patient Recruitment, 1-866-444-2214 (TTY for the deaf or hard of hearing: 1-866-411-1010) or email prpl@cc.nih.gov. Read more at https://go.usa.gov/xEYjh. Refer to study 18-CH-0120.